Millennium Management
ANEB

Millennium Management’s Anebulo Pharmaceuticals ANEB Stock Holding History

Millennium Management’s Portfolio ANEB Stock Details ANEB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-153,809
Closed -$221K – 5995
2025
Q2 		$221K Sell
153,809
-5,158
-3% -$5.88K ﹤0.01% 5319
2025
Q1 		$207K Buy
+158,967
New +$234K ﹤0.01% 5293

Other funds holding ANEB

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's ANEB Position: Q3 2025 in Review

Millennium Management sold out of Anebulo Pharmaceuticals (ANEB) in Q3 2025, closing a stake of 153,809 shares — an estimated $221K sold.

Millennium Management first reported a position in ANEB in Q1 2025 and held it in 2 quarters. The position peaked at $221K in Q2 2025. 21 funds tracked by Wall St. Rank hold ANEB as of Q3 2025.

  • Millennium Management reported no remaining Anebulo Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 153,809 Anebulo Pharmaceuticals shares in Q3 2025, an estimated $221K.
  • Millennium Management first reported a position in Anebulo Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Millennium Management's Anebulo Pharmaceuticals position peaked at $221K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.